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 Table 3 – Predictive factors in univariate analysis for local recurrence in 809 patients 




n = 26 (%) 
No local recurrence 
n = 783 (%) 
p 
Median age, yr 
(interquartile range) 
61.5 (54-67) 61(51-70) ns 
Sex, male (%) 18 (69.3%) 552 (70.5%) 
ns 
        female (%) 8 (30.7%) 231 (29.5%) 
Histology   
ns 
     Conventional RCC 19 (73.1%) 550 (70.3%) 
     Papillary RCC 3 (11.5%) 157 (20%) 
     Chromophobe RCC 1 (3.9%) 47 (6%) 
     Other 3 (11.5%) 29 (3.7%) 
Tumour location   
ns 
     Superior pole 9 (34.6%) 210 (26.8%) 
     Equatorial 12 (46.2%) 287 (36.7%) 
     Lower pole 3 (11.5%) 219 (28%) 
     Missing data 2 (7.7%) 67 (8.5%) 
Non exophytic tumour 6 (23.1%) 240 (30.6%) ns 
Hilar tumour 5 (19.2%) 79 (10.1%) ns 
pT3a stage 5 (19.2%) 59 (7.5%) 0.04 
N stage ≥ 1 0 12 (1.5%) ns 
M stage = 1 2 (7.7%) 29 (3.7%) ns 
Imperative Indication 21 (80.8%) 263 (33.6%) < 0.01 
Bilateral tumour  17 (65.4%) 168 (21.5%) < 0.01 
Tumour size > 4cm 15 (57.7%) 171 (21.8%) < 0.01 
Fuhrman grade 3 or 4 10 (38.5%) 156 (19.2%) 0.01 
Positive surgical margin 4 (15.4%) 8 (1%) < 0.01 
SD=Standard Deviation, RCC=Renal Cell Carcinoma, ns=not significant 
 
 
 
